This is a firm fixed-price purchase order awarded by the Federal Medical Center Carswell, a civilian agency, to Biologics, Inc. for the provision of a cancer drug for new inmates. The contract, valued at $21,535.58, has an ultimate completion date of September 30, 2024. Biologics, Inc. is a for-profit organization that provides specialty pharmaceuticals to government agencies, including the Department of Veterans Affairs and the Bureau of Prisons. Biologics, Inc. is a subsidiary of the larger...
This is a $21,535.58 firm fixed price purchase order awarded by the Federal Medical Center Carswell, a civilian agency, to Biologics, Inc., a for-profit pharmaceutical company, on January 10, 2025. The order is for the delivery of cancer drugs and biologics, with an ultimate completion date of January 10, 2025. Biologics, Inc. is a subsidiary of the larger McKesson Corporation, which is also a for-profit healthcare services and information technology company that holds various...
This is a firm fixed-price purchase order contract awarded by the Federal Medical Center Carswell, a civilian agency, to Biologics, Inc. to provide the cancer drug TURALIO 125MG. The order is for delivery during Fiscal Year 2025 with a completion date of February 18, 2025 and a ceiling value of $22,061.05. Biologics, Inc. is a for-profit organization that has previously held federal contracts to supply specialty pharmaceuticals to agencies such as the Department of Veterans Affairs and the...
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 19 to Biologics, Inc., a for-profit pharmaceutical provider, for $99,184.84. The contract is for express pharmacy orders, with a period of performance ending on September 30, 2017. Biologics, Inc. has provided specialty medications such as cancer treatments to VA medical centers and Bureau of Prisons facilities in the past. This award does not have a set-aside...
This is a firm fixed-price purchase order for $91,279.43 awarded by the Veterans Integrated Service Network 22, a component of the Department of Veterans Affairs (VA), to Biologics, Inc. to provide the cancer medication Lynparza on an emergency basis. The contract period was from November 6, 2015 to September 30, 2016. This contract was not set aside for any specific business category. Biologics, Inc. is a for-profit pharmaceutical company that has provided specialty medications to various...
This is a firm fixed price delivery order awarded by the Federal Medical Center Carswell, a civilian agency within the Department of Justice, to the prime contractor Mckesson Corporation. The $4,367,000.00 contract is for the provision of various medications during fiscal year 2016 and has an ultimate completion date of September 30, 2016. No set-aside designation was used. The award is associated with a larger indefinite delivery/indefinite quantity contract vehicle that Mckesson has used to...
This is a firm fixed price delivery order awarded by the Federal Medical Center Carswell, a civilian agency, to the prime contractor Mckesson Corporation. The $558,270.27 award is for the provision of pharmaceutical drugs and supplies to support the agency's medical operations in fiscal year 2024. No set-aside designation was used for this contract. Mckesson Corporation, doing business as Mckesson, is a healthcare services and IT company that has provided a range of pharmaceutical products and...
This is a firm fixed-price delivery order contract awarded by the Federal Medical Center Carswell (a civilian agency) to the prime contractor Mckesson Corporation, a prominent healthcare services and information technology company based in Irving, Texas. The contract, valued at $23,150.16, is for the provision of narcotics supplies for the fiscal year 2025. The contract does not have a set-aside designation. Mckesson Corporation is a critical vendor for the U.S. government's healthcare...
This federal contract award was issued by the Federal Medical Center Carswell, a civilian agency, to the prime contractor Mckesson Corporation, doing business as Mckesson. The contract, valued at $71,844.42, is for the delivery of pharmaceutical drugs to the agency during fiscal year 2024. It is a firm fixed price delivery order contract with an ultimate completion date of August 1, 2024. No set-aside designations were used. Mckesson Corporation is a healthcare services and information...
This is a firm fixed price delivery order awarded by the Federal Correctional Institution La Tuna, part of the U.S. Department of Justice, to Mckesson Corporation, a healthcare services and information technology company. The $100,000.00 contract is for the provision of medication to the prison, with a period of performance ending on July 31, 2018. The contract is not associated with any set-aside designation. Based on Mckesson's vendor profile, the company has significant experience providing...